Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Teva
Cantor Fitzgerald
AstraZeneca
Medtronic
Healthtrust
McKinsey
Federal Trade Commission
Fish and Richardson

Generated: June 21, 2018

DrugPatentWatch Database Preview

LOMAIRA Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Lomaira patents expire, and when can generic versions of Lomaira launch?

Lomaira is a drug marketed by Avanthi Inc and is included in one NDA.

The generic ingredient in LOMAIRA is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.
Drug patent expirations by year for LOMAIRA
Pharmacology for LOMAIRA
Synonyms for LOMAIRA
.alpha.-Methylamphetamine hydrochloride
.alpha.,.alpha.-Dimethylphenethylamine hydrochloride
(1,1-DIMETHYL-2-PHENYL)ETHYLAMINE HYDROCHLORIDE
0K2I505OTV
1-Phenyl-2-methyl-2-aminopropane hydrochloride
1-phenyl-2-methyl-2-aminopropanehydrochloride
1-Phenyl-2-methyl-2-propylamine Hydrochloride
1,1-Dimethyl-2-phenylethylamine hydrochloride
1197-21-3
122-09-8 (Parent)
2-Amino-2-methyl-1-phenylpropane hydrochloride
2-methyl-1-phenyl-2-propanamine hydrochloride
2-Methyl-1-phenylpropan-2-amine hydrochloride
2-methyl-1-phenylpropan-2-amine;hydrochloride
AC1L2F9M
Adipex-p (TN)
AK-81487
AKOS015891196
alpha-Methylamphetamine hydrochloride
alpha-methylamphetaminehydrochloride
alpha,alpha-dimethyl-phenethylaminhydrochloride
alpha,alpha-Dimethylphenethylamine hydrochloride
ANW-58508
AOB5784
API0007710
AS01627
BENZENEETHANAMINE, A,A-DIMETHYL-, HYDROCHLORIDE (1:1)
Benzeneethanamine, alpha,alpha-dimethyl-, hydrochloride
Benzeneethanamine, alpha,alpha-dimethyl, hydrochloride
Benzeneethanamine,.alpha.-dimethyl, hydrochloride
benzeneethanamine,alpha,alpha-dimethyl,hydrochloride
CCG-221139
CHEBI:50506
CHEMBL1200912
CTK6A7128
D05459
DEA No. 1640
DTXSID20152550
Duromine Hydrochloride
EINECS 214-821-9
Fastin
Fastin (TN)
FT-0673716
I01-8880
I14-44888
Inoamin Hydrochloride
Ionamin Hydrochloride
Linyl Hydrochloride
Lipopill Hydrochloride
Lonamin Hydrochloride
LS-103359
MG 18370
MG 18570
Mirapront Hydrochloride
MLS003882563
NCAIGTHBQTXTLR-UHFFFAOYSA-N
Normephentermine Hydrochloride
NSC 44090
NSC-44090
NSC44090
Obestin-30
Oby-Trim
Omnibex Hydrochloride
Ona-Mast
Ona-Mast hydrochloride
Phenethylamine, alpha,alpha-dimethyl-, hydrochloride
Phenteral
Phenteramine hydrochloride
Phentermine HCl
Phentermine hydrochloride
Phentermine hydrochloride (USP)
Phentermine hydrochloride [USAN]
Phentermine hydrochloride [USP]
Phentermine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Phentermyl Wyncaps
Phenyl-t-butylamine hydrochloride
phenyl-t-butylaminehydrochloride
Phenyl-tert-butylamine Hydrochloride
S 58
SCHEMBL41585
SMR000058739
Suprenza
TC-147253
TL8000587
Tora
UNII-0K2I505OTV
Wilpo (VAN)
Wilpo Hydrochloride
wilpohydrochloride
WLN: ZX1&1&1R &GH

US Patents and Regulatory Information for LOMAIRA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avanthi Inc LOMAIRA phentermine hydrochloride TABLET;ORAL 203495-001 Sep 12, 2016 AA RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
UBS
Citi
Mallinckrodt
Farmers Insurance
Cipla
McKesson
Merck
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.